Abstract
Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In placebo-controlled clinical studies, lamotrigine has been shown to be effective in reducing seizure frequency and the number of days with seizures when added to existing antiepileptic drug therapy in adult patients with partial seizures, with or without generalized tonic-clonic seizures, that are not satisfactorily controlled. Lamotrigine has emerged as a first line treatment for bipolar depression, which is an area of weakness for other mood stabilizers, with positive effect for resistant bipolar disorders and rapid cycling bipolar disorders. We review the Literature on the topic with a specific interest on bipolar disorders.
Keywords: Antiepileptic drugs, Bipolar depression, DSM-IV, double-blind maintenance, randomized controlled trials
Letters in Drug Design & Discovery
Title: Lamotrigine as an Effective Treatment for Behavioral Disorders
Volume: 4 Issue: 6
Author(s): Rita Moretti, Paola Torre, Cristina Vilotti and Rodolfo M. Antonello
Affiliation:
Keywords: Antiepileptic drugs, Bipolar depression, DSM-IV, double-blind maintenance, randomized controlled trials
Abstract: Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. In placebo-controlled clinical studies, lamotrigine has been shown to be effective in reducing seizure frequency and the number of days with seizures when added to existing antiepileptic drug therapy in adult patients with partial seizures, with or without generalized tonic-clonic seizures, that are not satisfactorily controlled. Lamotrigine has emerged as a first line treatment for bipolar depression, which is an area of weakness for other mood stabilizers, with positive effect for resistant bipolar disorders and rapid cycling bipolar disorders. We review the Literature on the topic with a specific interest on bipolar disorders.
Export Options
About this article
Cite this article as:
Rita Moretti , Paola Torre , Cristina Vilotti and Rodolfo M. Antonello , Lamotrigine as an Effective Treatment for Behavioral Disorders, Letters in Drug Design & Discovery 2007; 4 (6) . https://dx.doi.org/10.2174/157018007781387836
DOI https://dx.doi.org/10.2174/157018007781387836 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plant Derived Inhibitor Sulforaphane in Combinatorial Therapy Against Therapeutically Challenging Pancreatic Cancer
Anti-Cancer Agents in Medicinal Chemistry Cannabidiol Adverse Effects and Toxicity
Current Neuropharmacology Graphical Abstracts
Current Neuropharmacology Cytopathological Mechanisms in Mitochondrial Disease
Current Chemical Biology Drug Therapy for Patients with Eating Disorders
Current Drug Targets - CNS & Neurological Disorders The Role of Glial Cells in Drug Abuse
Current Drug Abuse Reviews Methylphenidate (Ritalin): What Makes it so Widely Prescribed During the Last 60 Years?
Current Drug Therapy The Role of Sodium Channels in the Mechanism of Action of Antidepressants and Mood Stabilizers
Current Drug Targets Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Current Medicinal Chemistry Valproate Induced Acute Pancreatitis - A Unique Case Report
Current Drug Safety ATP-Sensitive Potassium Channels
Current Pharmaceutical Design Delirium Secondary to Lamotrigine Toxicity
Current Drug Safety Interactions of β - and Hydroxypropyl-β-Cyclodextrin with Some Purine Alkaloids:Thermodynamic Study
Current Drug Discovery Technologies Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Protein & Peptide Letters Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Gene Therapy and Cell Reprogramming For the Aging Brain: Achievements and Promise
Current Gene Therapy History and Therapeutic Use of MAO-A Inhibitors: A Historical Perspective of MAO-A Inhibitors As Antidepressant Drug
Current Topics in Medicinal Chemistry Decreased ERp57 Expression in WAG/Rij Rats Thalamus and Cortex: Possible Correlation with Absence Epilepsy
Protein & Peptide Letters Impact of Dietary Fats on Brain Functions
Current Neuropharmacology Pharmacological Characterization of Ligands at Recombinant NMDA Receptor Subtypes by Electrophysiological Recordings and Intracellular Calcium Measurements
Combinatorial Chemistry & High Throughput Screening